HCA

HCA Healthcare, Inc.
NYSEHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$92.77B
P/E Ratio
13.07
EPS
$31.99
Beta
1.13
52W High
$554.58
52W Low
$350.75
50-Day MA
$387.94
200-Day MA
$457.48
Dividend Yield
0.77%
Profit Margin
8.77%
Forward P/E
13.00
PEG Ratio
1.26

About HCA Healthcare, Inc.

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$78.01B
Gross Profit (TTM)$33.22B
EBITDA$15.75B
Operating Margin15.20%
Return on Equity136.30%
Return on Assets12.30%
Revenue/Share (TTM)$345.26
Book Value$-28.32
Price-to-Book291.34
Price-to-Sales (TTM)1.19
EV/Revenue1.756
EV/EBITDA8.64
Quarterly Earnings Growth (YoY)11.60%
Quarterly Revenue Growth (YoY)8.70%
Shares Outstanding$221.84M
Float$150.16M
% Insiders16.21%
% Institutions78.52%

Historical Volatility

HV 10-Day
45.39%
HV 20-Day
50.52%
HV 30-Day
43.91%
HV 60-Day
36.64%
HV Rank
100.0%

Volatility is currently expanding

Analyst Ratings

Consensus ($452.81 target)
2
Strong Buy
13
Buy
9
Hold
1
Sell

Latest News

First Eagle U.S. Fund Q2 2026 Portfolio Review

U.S. Fund A Shares (without sales charge) posted a return of -0.04% in second quarter of 2026. Leading contributors in the First Eagle U.S. Fund this quarter included Alphabet Inc. Class C, Texas Instruments, Elevance Health, Bank of New York Mellon Corporation and Cummins. The leading detractors in the quarter were First Eagle Global Real Assets Cayman Fund Ltd. USD, HCA Healthcare, Charter Communications, Inc. Class A, Exxon Mobil and Salesforce.

Seeking Alpha7/28/2026Positive
HCA Healthcare Q2 Earnings Call Highlights

HCA Healthcare NYSE: HCA said its second-quarter performance reflected solid demand in several service lines and 11% growth in diluted earnings per share, but the company faced increased financial pressure as patients losing health insurance exchange coverage shifted largely into the uninsured population.

MarketBeat7/24/2026Negative
HCA (HCA) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research7/24/2026Neutral
HCA Healthcare (HCA) Q2 Earnings Surpass Estimates

HCA Healthcare (HCA) came out with quarterly earnings of $7.59 per share, beating the Zacks Consensus Estimate of $7.57 per share. This compares to earnings of $6.84 per share a year ago.

Zacks Investment Research7/24/2026Positive
HCA Healthcare Reports Second Quarter 2026 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2026. The Company's financial and operating results, as well as its updated guidance and key assumptions, are consistent with its July 14, 2026 second quarter preview. Key second quarter metrics (all percentage changes compare 2Q 2026 to 2Q 2025 unless otherwise noted): Revenues increased 8.7 percent to $20.230 billion Net income attributable.

Business Wire7/24/2026Neutral
HCA Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm

RADNOR, Pa., July 23, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by HCA Healthcare, Inc. (NYSE: HCA) on behalf of investors who purchased or acquired HCA Healthcare, Inc. securities and experienced significant financial losses.

PRNewsWire7/23/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HCA and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026